Watch the presentation from Redeye Investor Forum October 10th
Christer Ahlberg, CEO of Cinclus Pharma, was invited to present the company's latest updates and the development of linaprazan glurate at the Redeye Investor Forum on October 10th.
You can watch the full presentation in Swedish here.